Authors


Robert F. Schuldt, MA

Latest:

Reply to “Risk Adjustment in Home Health Care CAHPS”

The authors of “CMS HCC Risk Scores and Home Health Patient Experience Measures” respond to a letter to the editor.


Alina Denham, MS

Latest:

Did Medicaid Expansion Matter in States With Generous Medicaid?

Medicaid expansion significantly increased Medicaid coverage of the low-income population in New York and, specifically, that among the working poor in New York and Massachusetts.


Karen Davis, PhD, APN

Latest:

Innovative Care Models for High-Cost Medicare Beneficiaries: Delivery System and Payment Reform to Accelerate Adoption

This paper illustrates how Medicare Advantage plans and accountable care organizations could benefit from adopting innovative care delivery models, and suggests policy changes to accelerate spread.


Jerome O. Klein, MD

Latest:

Benefits and Risks of Live Attenuated Influenza Vaccine in Young Children

Use of live attenuated influenza vaccine in young children has a favorable benefit-risk profile.


Debbie L. Hettler, OD, MPH

Latest:

Impact of Clinical Training on Recruiting Graduating Health Professionals

A business case is made for medical centers to offer high-quality clinical training experiences to recruit graduating health professionals.


Srividya Kotapati, PharmD

Latest:

An Expanded Portfolio of Survival Metrics for Assessing Anticancer Agents

A novel, simplified cost-value analysis tool was created to better differentiate the value of anticancer agents and further characterize the expected survival benefit of all patients.




Samuel W. Woolford, PhD

Latest:

Process, Cost, and Clinical Quality: The Initial Oral Contraceptive Visit

Linking variation in process with cost and quality provides the opportunity for identifying low-cost, high-quality processes.




Gherta Brill, MD

Latest:

A Natural Experiment in Mass Media Modulated Pharmacokinetics After a Change in Tablet Formulation

Sporadic, unsubstantiated side effects were reported in the mass media after a formulation change of levothyroxine tablets induced patients to monitor thyroid-stimulating hormone levels and to unnecessarily stop taking medication.




Elizabeth Halprin, MD

Latest:

CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes

From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.


Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Latest:

Contributor: Patient-Centered Approaches to Supporting Medication Adherence Among Persons With Schizophrenia

There are effective strategies that can be employed concurrently to promote adherence to medications for schizophrenia, including but not limited to pharmacological, technological, and psychosocial interventions.


Sara Gale, MPH

Latest:

Estimated Effect of Asthma Case Management Using Propensity Score Methods

An asthma case management program increased preventive care but did not significantly decrease markers of exacerbations.




Mark Picciotto, PhD

Latest:

Assessing Outcomes in Child Psychiatry

Two standardized rating scales appeared to be valid and reliable for use at admission and possibly follow-up in a child psychiatry system of care.




Frances A. Smith, MD

Latest:

Improving Influenza Immunization in Pregnant Women and Healthcare Workers

Influenza vaccination rates in pregnant women and healthcare workers were increased with standing orders, vaccine advocates, and educational activities on influenza immunization.


James E. Pope, MD

Latest:

Impact of a Scalable Care Transitions Program for Readmission Avoidance

The 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.



Jan Berger, MD, MJ

Latest:

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.


Tanya G. K. Bentley, PhD

Latest:

Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer

A decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.


Christine Divers, PhD

Latest:

Improving Quality of Care in Oncology Through Healthcare Payment Reform

Overview of alternative payment models and how leading national organizations are involved with linking quality improvement initiatives and payment reform.



Janet Donegan, ANP-BC, AOCN

Latest:

A Step in the Digital Direction: From Paper Logs to Electronic Data Capture

Research documentation is a critical aspect of running a clinical trial. Key patient information such as informed consent, adverse events (AEs), concomitant medications, and medical and surgical histories are collected and used to determine patient safety and efficacy as the trial proceeds. Ultimately, the sponsor may make decisions—ranging from modifying the dose of the investigational drug to closing the study due to AEs—based on the data collected.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo